OUR EXPERTISE
Certifications
All American Pharmaceutical has earned the following certifications:
The Informed-Choice Site Registration is a unique certification that provides indepth analysis into critical control processes. Through regular on-site inspections and manufacturing facility swabbing, the Informed-Choice Registered Site program helps manufacturers identify and resolve areas of risk within the manufacturing process.
This facility has been audited by UL Registrar LLC and meets GMP requirements listed in (RCP, NBCP, or Pharmaceutical, (NPA) Certification Schemes which is uniquely accredited by the American National Standard Institute (ANSI) developed in accordance with applicable sections of the FDA’s code of federal regulations.
Additional Certifications & Accreditations
Informed-Choice Certificate
Informed-Sport Certificate
Informed-Choice/Sport Registered Site Certificate
MMEC Audit Certificate
2020 Montana DPHHS Food Manufacturing License
UL Registrar-NPA Certificate of Conformance, National Brand Certification, 21 CFR Part 111
Grants Received
2016 from the Montana Board of Research & Commercialization Technology "Transdermal Delivery of Nutraceuticals"
Grant Amount: $40,000.00
2015 from the Montana Board of Research & Commercialization Technology "Antilipidemic and anti-adipodicity impact of PTBP in mildly hyperlipidemic and overweight but otherwise healthy volunteers"
Grant Amount: $12,500.00
2014 from the Montana Board of Research & Commercialization Technology "KarboLyn A Unique Homopolysaccharide Compound for Glycogen Repletion in Athletes"
Grant Amount: $80,000.00
2010 from the Montana Board of Research & Commercialization Technology "Second Phase Clinical Trials of a Lypolytic Compound"
Grant Total: $25,000.00
2010 from the Montana Board of Research & Commercialization Technology "Clinical Trials of a Lypolytic Compound"
Grant Total $10,000.00
2008 from the Montana Board of Research & Commercialization Technology "Initial Clinical Pilot Trials and First-to-Market for Lipo-Effect , An all natural, non-prescription (OTC) designed to positively impact physiological Triglyceride & Cholesterol levels in humans".
Grant Total: $20,000.00
2007 from the Montana Board of Research & Commercialization Technology "Second Stage Field Clinical Trials & Bringing to Market of a Natural OTC ("Kre-Celazine") to Treat Chronic Inflammation".
Grant Total: $139,763.00
U.S. Advisory Committee
Chair of the Board
Wendy Jones (M.S.)
Rochester, MN
Board Member
Dr. Margaret Beeson (N.D., R.N.)
Yellowstone Naturopathic Clinic
Billings, MT
Board Member
Dr. Olivia Seddon (D.V.M.) Caring Hands Veterinary Hospital
Billings, MT
Board Member
Dr. Jensen Kolaczko (M.D.)
MS2 at WSU Boonshoft School of Medicine
Lorain, OH
Board Member
Rehan Jalali (C.S.N.)
Beverly Hills, CA
Board Member
Dr. Adam Rajouhl (M.D.)
Saint Agnes Medical Center
Fresno, CA
Board Member
Dr. Nadia Javaid (M.D.)
Avecinia Medical Center
Clovis, CA
Board Member
Ernie W. Carbone III
Advisor to Dr. Jeff Golini
Ocean City, NJ
International Advisory Committee
Chair of the Board Dr. Kamen Stoychev (M.D.) Sofia, Bulgaria
Board Member Dr. George Tsvetanoy Momekov (MPharm, Ph.D.) Sofia, Bulgaria